|
Species | I/R model | Drugs and dose | Effects and mechanisms | References |
|
Wistar rats: in vivo and in vitro | Ischemic 20 min, reperfusion 5 min | Phenazepam preconditioning 1 mg/kg | Anticonvulsant and antiarrhythmic effect by central nervous system | [191] |
Chick cardiomyocyte in vitro | Ischemia 1 h, reoxygenation 3 h | Flumazenil preconditioning 10 μmol/L | Inhibiting ROS/mitochondrial K(ATP) channel | [192] |
Chick cardiomyocyte in vitro | Ischemia 10 min, reoxygenation 10 min | Flumazenil preconditioning 10 μmol/L | Inhibiting protein kinase C/mitochondrial K(ATP) channel | [193] |
Chick embryonic cardiomyocyte in vitro | Hypoxia 1 h, reoxygenation 3 h | Diazepam preconditioning (100 μmol/L) | Inhibiting protein kinase C epsilon | [194] |
Isolated rat heart ex vitro | LPS-induced ischemia 5 h, reoxygenation 20 min | Diazepam in reperfusion (3.0 μg/mL) | Myocardial functional parameters and coronary flow | [195] |
Rat cardiomyocytes in vitro | Hypoxia 1 h, subsequent reoxygenation | Clonazepam in reoxygenation (100 μmol/L) | Ca2+ accumulation by reducing Ca2+ influx and preserves mitochondrial membrane potential | [196] |
|